Japan Exchange
02:00:00 2024-04-25 am EDT
5-day change
1st Jan Change
2,490
JPY
-0.44%
+0.04%
+30.71%
Daito Pharmaceutical Co.,Ltd. announced that it has received ¥7.836 million in funding from Daiwa Securities Co., Ltd., Investment Arm
On September 24, 2019, Daito Pharmaceutical Co.,Ltd. (TSE:4577) closed the transaction.
Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 350,000 shares, representing 2.23% for ¥1,000 million.
Apr. 12
CI
Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
Apr. 11
CI
Tranche Update on Daito Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 12, 2024.
Jan. 14
CI
Daito Pharmaceutical Co.,Ltd.'s Equity Buyback announced on January 12, 2024, has closed with 160,000 shares, representing 0.93% for ¥303.36 million.
Jan. 14
CI
Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 160,000 shares, representing 1.01% for ¥303.36 million.
Jan. 12
CI
Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
Jan. 11
CI
Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 160 shares.
23-09-14
CI
Daito Pharmaceutical Co.,Ltd.'s Equity Buyback announced on September 14, 2023, has expired.
23-09-13
CI
Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.
23-09-13
CI
Daito Pharmaceutical Co.,Ltd. announced that it has received ¥13.351 million in funding from Daiwa Securities Co., Ltd., Investment Arm
21-09-28
CI
Daito Pharmaceutical Co.,Ltd. announced that it expects to receive ¥13.351 million in funding from Daiwa Securities Co., Ltd., Investment Arm
21-09-12
CI
Daito Pharmaceutical Co.,Ltd. announced that it has received ¥7.836 million in funding from Daiwa Securities Co., Ltd., Investment Arm
19-09-23
CI
Daito Pharmaceutical Co.,Ltd. announced that it expects to receive ¥7.836 million in funding from Daiwa Securities Co., Ltd., Investment Arm
19-09-05
CI
Anhui Tingworld Pharmaceutical Co., Ltd announced that it expects to receive funding from Daito Pharmaceutical Co.,Ltd. and another investor
19-03-07
CI
Cheer Fine Pharmaceutical Co., Ltd. announced that it expects to receive $4 million in funding from Daito Pharmaceutical Co.,Ltd., Cheer Fine Enterprises Co., Ltd., Nikoshoji co.ltd
19-03-07
CI
Certain shares of Daito Pharmaceutical Co., Ltd.'s Shares are subject to a Lock-Up Agreement Ending on 25-JAN-2015.
15-01-24
CI
Cheer Fine Pharmaceutical Co., Ltd. announced that it expects to receive $3 million in funding from Cheer Fine Enterprises Co., Ltd. and Daito Pharmaceutical Co., Ltd.
14-04-11
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Daito Pharmaceutical Co., Ltd. is a Japan-based company mainly engaged in the pharmaceutical ingredients and formulation business, as well as healthy food. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.
More about the company
Last Close Price
2,501
JPY
Average target price
3,155
JPY
Spread / Average Target
+26.15%
Consensus
1st Jan change
Capi.
+30.71% 252M +19.89% 42.78B +18.59% 22.25B +13.12% 14.39B +12.17% 13.55B +35.81% 11.27B -9.80% 6.95B -0.05% 6.79B -8.87% 5.73B +6.29% 5.01B
Generic Pharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
DAITO PHARMACEUTICAL CO.,LTD. 
